Send mail to Author

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus : a randomized, placebo-controlled phase II AIO trial with serum biomarker program (Article)

Please indicate your contact information and select, which author you want to contact.



 
            _____     _____    __   __   ______      ___    
  ____     |  ___||  |__  //   \ \\/ // |      \\   / _ \\  
 |    \\   | ||__      / //     \ ` //  |  --  //  / //\ \\ 
 | [] ||   | ||__     / //__     | ||   |  --  \\ |  ___  ||
 |  __//   |_____||  /_____||    |_||   |______// |_||  |_||
 |_|`-`    `-----`   `-----`     `-`'   `------`  `-`   `-` 
 `-`
 


Back to frontdoor view

OPUS4 Logo